MBCA WEBINAR: Clinical Trial Endpoints Survey Results

Metastatic Breast Cancer Patient Input Regarding Clinical Trial Endpoints: Update on Research Advocacy Network Survey REGISTER HERE! Endpoints for clinical trials studying metastatic breast cancer (MBC), in particular the patient perspective, has been the subject of much discussion in recent years. In 2017, the Research Advocacy Network (RAN) conducted focus groups with patients with MBC […]

WEBINAR: Metastatic Trial Talk Overview

VIA ZOOM

On Wednesday, July 25 at 12:30 PM Eastern, the MBC Alliance will host our member organization, BreastCancerTrials.org, for an overview of their exciting new offering for MBC patients as well as their families and friends: Metastatic Trial Talk. Elly Cohen and Susan Colen will give us an overview of the new companion application to the […]

WEBINAR: Hereditary Breast Cancer and Genetic Testing

VIA ZOOM

Some breast cancers are thought to be hereditary, caused by abnormal genes passed from parent to child. Most cases of hereditary breast cancer are associated with inherited mutations in two genes: BRCA1 (BReast CAncer gene one) and BRCA2 (BReast CAncer gene two). Together BRCA1 and BRCA2 mutations account for about 25 to 30 percent of […]

BLACK WO(MEN) SPEAK SYMPOSIUM

La Quinta (Riverwalk) Hotel 303 Blum Street, San Antonio, United States

The Black Wo(Men) Speak Symposium was initiated as a response to the BECOME (Black Experience of Clinical Trials and Opportunities for Meaningful Engagement) survey conducted by the Metastatic Breast Cancer Alliance (MBCA) which found that 8 out of 10 Black people living with metastatic breast cancer would consider participating in clinical trials, but that only […]